Viewing Study NCT02987504


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-01-04 @ 11:01 AM
Study NCT ID: NCT02987504
Status: TERMINATED
Last Update Posted: 2018-07-18
First Post: 2016-11-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Samalizumab in Patients With Advanced Cancer
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module